ADXN Addex Therapeutics Ltd Accounting Capitalization

Public company logo of Addex Therapeutics Ltd (ADXN)

The current state of Addex Therapeutics (ADXN) relies on partner payments, which provide temporary support for the company in the absence of its own products. The biotech's strategy focuses on developing precision treatments for dystonia and Parkinson's disease. The price action on GURU.Markets, where the indicator stands at 0.00, depends on the outcomes of tests with Janssen and the prospects of receiving royalties for receptor modulation.

ADXN Addex Therapeutics Ltd Book Capitalization (07/04/2022 - 10/27/2026)

Metric breakdowns and analytics for Addex Therapeutics Ltd (ADXN)

- price and consensus price forecast:
Share Price Addex|ADXN - Price Target Chart
- market capitalization data:
Market Capitalization Addex Therapeutics Ltd.|ADXN - Total Company Value
- book capitalization data:
Equity per Share Addex Therapeutics|ADXN - Book Capitalization|Market-to-Book Ratio addextherapeutics.com|ADXN - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Addex Therapeutics|ADXN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Addex Therapeutics Ltd.|ADXN - Company Debts|Debts to Book Value Addex Therapeutics Ltd.
Summary company analysis:ADXN - Addex
Flagship merchandise of Addex Therapeutics Ltd.

Book value capitalization reflects the actual value of Addex Therapeutics (ADXN) net assets minus all liabilities, allowing investors to filter out market noise and assess the business's intrinsic stability. By analyzing changes in the book value of equity, one can diagnose the effectiveness of investments in green drug synthesis and the implementation of zero-waste laboratory technologies, which minimize chemical disposal costs.

Competitor analysis for Addex Therapeutics

BIIB: Accounting Capitalization|Company Book Value Neurocrine Biosciences|RGC (regencellbioscience.com) - Accounting Capitalization|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|Amylyx Corp (AMLX) - Total Stockholders' Equity|TRVI (Trevi Therapeutics) - Book Capitalization|Book Capitalization praxismedicines.com|Book Capitalization Anavex Life Sciences Corp. AVXL|Accounting Capitalization CeriBell Inc (CBLL)|PRTA - Book Capitalization|Accounting Capitalization Alector Inc. ALEC|ANNX (Annexon, Inc.) - Book Capitalization|Omeros Corporation (OMER) - Total Stockholders' Equity|Company Net Assets Neurogene|Accounting Capitalization AC Immune S.A.|VYGR - Company Net Assets|Accounting Value of Company Neumora Corp (NMRA)|Company Net Assets Scilex Holding Company|Total Net Assets tevogen.com (TVGN)|Book Capitalization Alpha Cognition Inc.|Accounting Value of Company cogrx.com CGTX|IKT (Inhibikase) - Book Capitalization|SAVA: Total Stockholders' Equity|Company Book Value assertiotx.com ASRT|Coya Therapeutics (COYA) - Accounting Value of Company|VTGN (VistaGen Therapeutics, Inc.) - Book Capitalization|Book Capitalization OVID|ABOS - Company Book Value|Net Asset Value CervoMed Corporation (CRVO)|ATHE: Book Capitalization|CLNN - Total Stockholders' Equity|PepGen Corp - Company Net Assets|jupiterneurosciences.com (JUNS) - Book Capitalization|RLMD - Company Net Assets|Annovis Bio Corporation (ANVS) - Total Net Assets|GRCE: Book Capitalization|Book Valuation of Business fireflyneuro.com|Book Capitalization KLTO (Klotho Neurosciences Inc)|Company Net Assets NRSN (neurosense-tx.com)|Company Book Value RVPH|Book Valuation of Business MetaVia Inc. MTVA|NeurAxis, Inc. - Book Capitalization|HSDT - Book Capitalization|Book Capitalization passagebio.com|Accounting Capitalization Neuphoria Therapeutics|Company Net Assets Minerva Neurosciences Corp (NERV)|Accounting Capitalization ATHA|Company Book Value Alzamend Neuro, Inc. ALZN|Accounting Capitalization CYCN (cyclerion.com)|PTIX - Company Book Value|Accounting Capitalization Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Book Capitalization|Avenue Therapeutics Inc (ATXI) - Total Stockholders' Equity|BCLI: Company Net Assets|CARA (caratherapeutics.com) - Book Capitalization|CHRO - Company Book Value|Accounting Value of Company ELYM|Intra-Cellular Therapies - Company Book Value|Total Stockholders' Equity Longboard (LBPH)|Book Capitalization MRNS (Marinus Pharmaceuticals)|Book Capitalization nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. (NRBO) - Book Capitalization|SAGE - Accounting Capitalization|Book Capitalization Neurotrope|Trevena Inc (TRVN) - Accounting Capitalization|Book Capitalization VIGL (Vigil Neuroscience Inc.)|Total Stockholders' Equity Anew Medical Inc. (WENA)|Company Net Assets Cerevel Therapeutics, Inc. CERE